Article Detail - JF Part B
Billing and Coding: MolDX: Pharmacogenomics Testing (A57385) - R19 - Effective July 2, 2024
Date Posted: February 5, 2026
This Billing and Coding Article has been revised under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).
Effective Date: July 2, 2024
Summary of Changes:
Under Article Text revised Table 2 APOE row to add donanemab. This revision is due to FDA guidelines and is effective 7/2/2024.
Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.